Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
51.88
-1.59 (-2.97%)
Mar 3, 2026, 4:00 PM EST - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $346.69 million as of March 4, 2026. Its market cap has increased by 27.24% in one year.
Market Cap
346.69M
Enterprise Value
203.12M
1-Year Change
27.24%
Ranking
Category
Stock Price
$51.88
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $346.69M, an increase of 25.54%. That is a compound annual growth rate of 3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 357.32M | -18.12% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 392.90M |
| Armata Pharmaceuticals | 391.74M |
| Candel Therapeutics | 384.55M |
| Greenwich LifeSciences | 384.05M |
| NovaBridge Biosciences | 378.15M |
| Aura Biosciences | 374.03M |
| Benitec Biopharma | 373.38M |
| Cybin | 367.76M |